发明名称 Modified HCV NS5
摘要 The present invention relates to peptides or polypeptides comprising an HCV NS5 protein or a part thereof or a derivative of said peptide or polypeptide, HCV NS5 protein or part thereof wherein at least one cysteine is reversibly or irreversibly modified. These modified HCV NS5 proteins have advantageous properties both for diagnostic and therapeutic/prophylactic applications.
申请公布号 US2005014136(A1) 申请公布日期 2005.01.20
申请号 US20040855897 申请日期 2004.05.28
申请人 INNOGENETICS N.V. 发明人 DEPLA ERIK;MAERTENS GEERT;BOSMAN FONS
分类号 C07K14/18;C12N7/01;G01N33/569;(IPC1-7):C12Q1/70;A61K39/29;C12N7/00;G01N33/564;G01N33/53;C07H21/04 主分类号 C07K14/18
代理机构 代理人
主权项
地址